About: http://data.cimple.eu/news-article/404c3521b6ba3a8873bdb9cb784fd6f075f0e798bdb95ff70c53a7bb

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/404c3521b6ba3a8873bdb9cb784fd6f075f0e798bdb95ff70c53a7bb Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	The head of the European Union's coronavirus vaccine supply task force on Thursday slammed AstraZeneca's efforts as "not good enough" to meet delivery obligations for the first quarter of 2021. "AstraZeneca vaccines delivery: I see efforts, but not 'best efforts'," Thierry Breton, the bloc's industry commissioner, wrote on Twitter. "That's not good enough yet for AstraZeneca to meet its Q1 obligations." Breton insisted: "It's time for AstraZeneca's Board to exercise its fiduciary responsibility and now do what it takes to fulfil AZ's commitments." The comments are the latest in a bitter spat between the European Commission and the pharmaceutical giant over major shortfalls in its vaccine deliveries to the 27-nation bloc. Problems with supplies have contributed to a stuttering inoculation rollout that has left EU nations trailing behind the likes of the United States, Britain and Israel. AstraZeneca has admitted it is facing a delivery deficit to the EU of around 60 percent of the 100 million doses meant to be supplied between January and March. The company blamed it on low production yields in the EU factories making its vaccines but said it hoped to improve production in the second quarter of 2021. The European Commission, suspicious that some AstraZeneca vaccine produced in the EU had been sent to Britain, on January 29 launched a scheme to monitor -- and if necessary, block -- exports of Covid vaccines from the EU. Europe's strategy faced fresh problems on Thursday as Denmark, Norway and Iceland said they were temporarily suspending the use of AstraZeneca's Covid-19 vaccine after some patients developed blood clots. Norway and Iceland are not in the EU but are covered by the bloc's medicines regulator the EMA. The EMA said the vaccine was still safe for use, pending an investigation. The EU on Thursday gave approval to a fourth vaccine, a single-jab shot from Johnson & Johnson, as it looks to meet a target to inoculate 70 percent of adults by mid-September. del/mjs
schema:headline	EU says AstraZeneca efforts 'not good enough' on deliveries
schema:mentions	Fiduciary Inoculation Stuttering European Commission European Medicines Agency Johnson & Johnson Medication Iceland Denmark Norway AstraZeneca Arizona Israel European Union Twitter Coronavirus disease Vaccine United States Coronavirus Coronavirus disease 2019 Bretons Augustin Thierry
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-03-11 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	positive sentiment
http://data.cimple...readability_score	80 (xsd:integer)

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software